Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
Inspire Medical Systems (NYSE: INSP) has announced the appointment of two leading physicians as Vice President, Senior Medical Directors. Dr. Paul T. Hoff, an otolaryngologist, and Dr. Ruchir P. Patel, a sleep medicine specialist, will join the company effective April 21 and June 2, respectively.
Dr. Hoff, an Associate Professor at the University of Michigan with over 25 years of clinical practice, has served as President of both the Michigan Otolaryngology Society and International Surgical Sleep Society. Dr. Patel, founder of The Insomnia and Sleep Institute of Arizona, brings 15 years of clinical experience and expertise in sleep disorders medicine.
Both physicians will maintain their independent clinical practices while contributing to Inspire's medical education, training, and future technology developments for obstructive sleep apnea (OSA) treatment solutions.
Inspire Medical Systems (NYSE: INSP) ha annunciato la nomina di due medici di spicco come Vice Presidenti e Senior Medical Directors. Il dott. Paul T. Hoff, otorinolaringoiatra, e il dott. Ruchir P. Patel, specialista in medicina del sonno, entreranno in azienda rispettivamente il 21 aprile e il 2 giugno.
Il dott. Hoff, Professore Associato all'Università del Michigan con oltre 25 anni di esperienza clinica, è stato Presidente sia della Michigan Otolaryngology Society che della International Surgical Sleep Society. Il dott. Patel, fondatore del The Insomnia and Sleep Institute of Arizona, vanta 15 anni di esperienza clinica e competenze nella medicina dei disturbi del sonno.
Entrambi i medici manterranno la loro attività clinica indipendente, contribuendo allo stesso tempo all'educazione medica, alla formazione e allo sviluppo tecnologico futuro di Inspire per le soluzioni di trattamento dell'apnea ostruttiva del sonno (OSA).
Inspire Medical Systems (NYSE: INSP) ha anunciado el nombramiento de dos destacados médicos como Vicepresidentes y Directores Médicos Senior. El Dr. Paul T. Hoff, otorrinolaringólogo, y el Dr. Ruchir P. Patel, especialista en medicina del sueño, se incorporarán a la empresa el 21 de abril y el 2 de junio, respectivamente.
El Dr. Hoff, Profesor Asociado en la Universidad de Michigan con más de 25 años de práctica clínica, ha sido Presidente tanto de la Michigan Otolaryngology Society como de la International Surgical Sleep Society. El Dr. Patel, fundador del The Insomnia and Sleep Institute of Arizona, aporta 15 años de experiencia clínica y especialización en medicina de trastornos del sueño.
Ambos médicos mantendrán sus prácticas clínicas independientes mientras contribuyen a la educación médica, formación y futuros desarrollos tecnológicos de Inspire para soluciones de tratamiento de la apnea obstructiva del sueño (AOS).
Inspire Medical Systems (NYSE: INSP)는 두 명의 저명한 의사를 부사장 겸 수석 의료 이사로 임명했다고 발표했습니다. Paul T. Hoff 박사는 이비인후과 전문의이며, Ruchir P. Patel 박사는 수면 의학 전문가로 각각 4월 21일과 6월 2일부로 회사에 합류할 예정입니다.
Hoff 박사는 미시간 대학교 부교수로 25년 이상의 임상 경력을 보유하고 있으며, 미시간 이비인후과 학회와 국제 수면 수술 학회의 회장을 역임했습니다. Patel 박사는 애리조나 불면증 및 수면 연구소를 설립했으며, 수면 장애 의학 분야에서 15년간의 임상 경험과 전문 지식을 갖추고 있습니다.
두 의사 모두 독립적인 임상 진료를 유지하면서 Inspire의 의학 교육, 훈련 및 폐쇄성 수면 무호흡증(OSA) 치료 솔루션의 미래 기술 개발에 기여할 예정입니다.
Inspire Medical Systems (NYSE : INSP) a annoncé la nomination de deux médecins de premier plan en tant que vice-présidents et directeurs médicaux seniors. Le Dr Paul T. Hoff, oto-rhino-laryngologiste, et le Dr Ruchir P. Patel, spécialiste en médecine du sommeil, rejoindront l'entreprise respectivement le 21 avril et le 2 juin.
Le Dr Hoff, professeur associé à l'Université du Michigan avec plus de 25 ans de pratique clinique, a été président de la Michigan Otolaryngology Society ainsi que de l'International Surgical Sleep Society. Le Dr Patel, fondateur de l'Insomnia and Sleep Institute of Arizona, apporte 15 ans d'expérience clinique et une expertise en médecine des troubles du sommeil.
Les deux médecins conserveront leur pratique clinique indépendante tout en contribuant à la formation médicale, à l'éducation et aux futurs développements technologiques d'Inspire pour les solutions de traitement de l'apnée obstructive du sommeil (AOS).
Inspire Medical Systems (NYSE: INSP) hat die Ernennung von zwei führenden Ärzten zu Vizepräsidenten und Senior Medical Directors bekannt gegeben. Dr. Paul T. Hoff, ein Hals-Nasen-Ohren-Arzt, und Dr. Ruchir P. Patel, ein Spezialist für Schlafmedizin, werden dem Unternehmen zum 21. April bzw. 2. Juni beitreten.
Dr. Hoff, außerordentlicher Professor an der University of Michigan mit über 25 Jahren klinischer Erfahrung, war Präsident sowohl der Michigan Otolaryngology Society als auch der International Surgical Sleep Society. Dr. Patel, Gründer des Insomnia and Sleep Institute of Arizona, bringt 15 Jahre klinische Erfahrung und Fachwissen im Bereich der Schlafstörungen mit.
Beide Ärzte werden ihre unabhängige klinische Praxis beibehalten und gleichzeitig zu Inspires medizinischer Ausbildung, Schulung und zukünftigen technologischen Entwicklungen für Behandlungslösungen der obstruktiven Schlafapnoe (OSA) beitragen.
- Strategic addition of two renowned sleep medicine experts to strengthen medical leadership
- Enhancement of medical education and training capabilities
- Potential advancement in future technology developments for OSA treatment
- None.
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively.
“Dr. Hoff and Dr. Patel are widely regarded as experts and thought leaders in their respective fields, and we are excited to bring their expertise and passion to the Inspire team. Dr. Hoff and Dr. Patel are both highly experienced in treating sleep apnea patients including extensive work with Inspire therapy. They will play key roles in guiding Inspire’s medical education, training and future technology developments to drive continued adoption of Inspire therapy,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire.
Dr. Hoff received his Doctor of Medicine (M.D.) degree from the University of Michigan Medical School with honors and completed his residency at Michigan. Upon completion of his training, he joined Michigan Otolaryngology Surgery Associates as a comprehensive otolaryngologist with a special interest in sleep apnea. He joined the faculty at the University of Michigan in 2014, where he is currently an Associate Professor.
Dr. Hoff has been involved in leadership positions during his career both regionally as President of the Michigan Otolaryngology Society and internationally as President of the International Surgical Sleep Society (ISSS) and has been in clinical practice for over 25 years.
“I am very honored to join Inspire. My career has focused on driving innovation and improved outcomes for patients with obstructive sleep apnea, a vision shared by the leadership and team members at Inspire. I look forward to bringing my experience in the field of sleep surgery to help guide Inspire in their mission of serving the many patients with untreated OSA,” said Dr. Hoff.
Dr. Patel earned his Doctor of Medicine (M.D.) degree from the Royal College of Surgeons in Ireland, followed by a residency in Internal Medicine at Henry Ford Hospital in Detroit. Dr. Patel then completed a fellowship in Sleep Disorders Medicine at Rush University Medical Center in Chicago.
Dr. Patel founded The Insomnia and Sleep Institute of Arizona, a leading practice dedicated to evidence-based approaches to treat sleep disorders. He has served as a principal investigator in multiple clinical trials in sleep medicine and neuromodulation and is a published researcher in the field of hypoglossal nerve stimulation. Dr. Patel is a highly sought after lecturer on the topics of precision sleep medicine and neuromodulation and has been in clinical practice for over 15 years.
“Inspire has redefined what’s possible in sleep medicine, and I’m truly honored and excited to be able to contribute to a future where technology and compassionate care come together to transform lives on a global scale,” said Dr. Patel.
Both Dr. Hoff and Dr. Patel will maintain their clinical practices independent from Inspire.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and important factors could cause actual results to differ materially from those anticipated, including the factors identified under the captions “Risk Factors” and “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC, and as such factors may be updated from time to time in our other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and the Investors page of our website at www.inspiresleep.com. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
What roles will Dr. Hoff and Dr. Patel have at Inspire Medical Systems (INSP)?
When will the new medical directors start their positions at INSP?
What is Dr. Hoff's background and experience in sleep medicine?
What is Dr. Patel's expertise in sleep medicine?
